See today's BioWorld
To read the full story, subscribe or sign in.

Aussie radiopharma Telix raises AU$40M as it advances to late-stage trials

July 31, 2019
By Tamra Sami
PERTH, Australia – Telix Pharmaceuticals Ltd. raised AU$40 million as it prepares regulatory packages and commercial strategies in Europe, the U.S. and Australia.
BioWorld Clinical Financings Diagnostics Imaging Australia